Ducommun’s second quarter was marked by strong demand across its core aerospace and defense markets, resulting in financial results that exceeded Wall Street expectations and a positive market reaction. Management attributed this performance to continued execution of its VISION 2027 strategy, with particular emphasis on expanding engineered product content, capitalizing on commercial aerospace recovery, and robust growth in missile programs. CEO Stephen Oswald highlighted that a 68% increase in missile-related sales and new aftermarket retrofit orders for the 737 MAX platform were major contributors to quarterly momentum.

Is now the time to buy DCO? Find out in our full research report (it’s free for active Edge members).

While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From Ducommun’s Q2 Earnings Call

• John Godyn (Citi) asked about the pronounced acceleration in missile sales and the details behind the 68% growth. CEO Stephen Oswald attributed this primarily to PAC-3 orders and highlighted Ducommun’s position as a key supplier for critical missile components.
• John Godyn (Citi) also inquired about the nature and expected impact of the 737 MAX retrofit order. CFO Suman Mookerji explained this was a proprietary engineered win expected to generate recurring revenue as both retrofit and line-fit demand progresses.
• Michael Crawford (B. Riley Securities) questioned Ducommun’s engagement with emerging defense primes and opportunities in affordable mass production. Oswald responded that the company is actively working with new entrants like Anduril and AeroVironment, focusing on differentiated components such as composites and RF antennas.
• Michael Crawford (B. Riley Securities) further probed Ducommun’s M&A strategy, asking about appetite for larger deals. Mookerji confirmed that the company is actively evaluating larger, value-creating opportunities, with more details to be shared at Investor Day.
• Kenneth Herbert (RBC Capital Markets) sought clarity on margin tailwinds beyond volume and price, specifically the role of engineered product mix. Mookerji emphasized that further margin expansion is expected as engineered product revenue continues to grow, both organically and via M&A.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be closely watching (1) the pace at which missile program ramps and new framework agreements convert into firm orders, (2) the continued expansion of engineered product content and associated margin improvement, and (3) signs of sustained commercial aerospace recovery in light of ongoing destocking and supply chain normalization. Execution on the M&A front and progress toward VISION 2027 milestones will also be key areas of focus.

Ducommun currently trades at $201.13, up from $191.72 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.